Inhibition of cyclin dependent kinase 9 by dinaciclib suppresses cyclin B1 expression and tumor growth in triple negative breast cancer

Authors

Sandeep Rajput, Washington University School of Medicine in St. Louis
Nimmish Khera, Washington University School of Medicine in St. Louis
Zhanfang Guo, Washington University School of Medicine in St. Louis
Jeremy Hoog, Washington University School of Medicine in St. Louis
Shunqiang Li, Washington University School of Medicine in St. Louis
Cynthia X. Ma, Washington University School of Medicine in St. Louis

Journal

Oncotarget

Publication Date

2016

Volume

7

Issue

35

Inclusive Pages

56864-56875

Document Type

Open Access Publication

Rights and Permissions

Rajput, S., Khera, N., Guo, Z., Hoog, J., Li, S., & Ma, C. X. (2016). Inhibition of cyclin dependent kinase 9 by dinaciclib suppresses cyclin B1 expression and tumor growth in triple negative breast cancer. Oncotarget, 7(35), 56864-56875. 10.18632/oncotarget.10870. Copyright: © Rajput et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Recommended Citation

Rajput, Sandeep; Khera, Nimmish; Guo, Zhanfang; Hoog, Jeremy; Li, Shunqiang; and Ma, Cynthia X., "Inhibition of cyclin dependent kinase 9 by dinaciclib suppresses cyclin B1 expression and tumor growth in triple negative breast cancer." Oncotarget. 7, 35. 56864-56875. (2016).
https://digitalcommons.wustl.edu/open_access_pubs/5163